|
gptkbp:instanceOf
|
gptkb:neurological_disorder
|
|
gptkbp:affects
|
elderly population
|
|
gptkbp:alsoKnownAs
|
gptkb:atypical_parkinsonism
|
|
gptkbp:associatedWith
|
gptkb:synucleinopathy
gptkb:tauopathy
|
|
gptkbp:cause
|
neurodegeneration
|
|
gptkbp:characterizedBy
|
parkinsonism with additional features
|
|
gptkbp:diagnosedBy
|
neuroimaging
clinical evaluation
|
|
gptkbp:distinctiveFeature
|
gptkb:Parkinson's_disease
|
|
gptkbp:field
|
neurology
|
|
gptkbp:firstDescribed
|
20th century
|
|
gptkbp:includes
|
gptkb:dementia_with_Lewy_bodies
gptkb:corticobasal_degeneration
gptkb:multiple_system_atrophy
gptkb:progressive_supranuclear_palsy
|
|
gptkbp:notResponsiveTo
|
levodopa (as well as Parkinson's disease)
|
|
gptkbp:prognosis
|
generally poorer than Parkinson's disease
|
|
gptkbp:symptom
|
bradykinesia
postural instability
rigidity
cognitive impairment
autonomic dysfunction
|
|
gptkbp:treatment
|
symptomatic management
|
|
gptkbp:bfsParent
|
gptkb:The_Cambridge_Centre_for_Parkinson-Plus
gptkb:Atypical_Parkinsonian_Syndromes
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Parkinson-plus syndromes
|